Related references
Note: Only part of the references are listed.Conjugated Linoleic Acid Ameliorates High Fructose-Induced Hyperuricemia and Renal Inflammation in Rats via NLRP3 Inflammasome and TLR4 Signaling Pathway
Jianyang Tan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease
Baban S. Thawkar et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
Fan Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Mariel F. van Stee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Min Li et al.
FRONTIERS IN PHYSIOLOGY (2018)
Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy
Ahmed A. M. Abdel-Hamid et al.
JOURNAL OF MOLECULAR HISTOLOGY (2018)
Safety and efficacy of statin therapy
Bhavin B. Adhyaru et al.
NATURE REVIEWS CARDIOLOGY (2018)
Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
Ki Hoon Han
KOREAN CIRCULATION JOURNAL (2018)
Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats
Nawal M. Al-Rasheed et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy
Aude Carillion et al.
PLOS ONE (2017)
Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet
Fei Luo et al.
SCIENTIFIC REPORTS (2017)
Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia
Xiaozhen Dai et al.
CIRCULATION RESEARCH (2017)
The diabetogenic action of statins - mechanisms and clinical implications
D. John Betteridge et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Diabetic cardiomyopathy: role of the E3 ubiquitin ligase
Tao Bai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress
Ahmed A. M. Abdel-Hamid et al.
JOURNAL OF MOLECULAR HISTOLOGY (2015)
Metformin enhances the anti-adipogenic effects of atorvastatin via modulation of STAT3 and TGF-β/Smad3 signaling
Byung-Hak Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
Beibei Luo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation
Yuguang Zhao et al.
DIABETES (2013)
AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy
Zhonglin Xie et al.
AUTOPHAGY (2011)
Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
P. Matafome et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Myocardial Oxygen Consumption Change Predicts Left Ventricular Relaxation Improvement in Obese Humans After Weight Loss
C. Huie Lin et al.
OBESITY (2011)
Direct effect of cholesterol on insulin secretion -: A novel mechanism for pancreatic β-cell dysfunction
Mingming Hao et al.
DIABETES (2007)
Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
ZY Fang et al.
ENDOCRINE REVIEWS (2004)
Share Paper
